View in EDS HTML Full Text PDF Full Text

Beyond Glycemic Control: Concurrent GLP-1 Receptor Agonist Use Is Associated with Reduced Urinary Adverse Events Following OnabotulinumtoxinA Treatment in Non-Diabetic Adults with Overactive Bladder.

Saved in:
Bibliographic Details
Title: Beyond Glycemic Control: Concurrent GLP-1 Receptor Agonist Use Is Associated with Reduced Urinary Adverse Events Following OnabotulinumtoxinA Treatment in Non-Diabetic Adults with Overactive Bladder.
Authors: Hammad, Muhammed A. M.1 (AUTHOR), Quesada, Sophia G.1 (AUTHOR), Belczyk, Aimee L.1 (AUTHOR), Ghoniem, Gamal M.1 (AUTHOR) gghoniem@hs.uci.edu
Source: Toxins. Nov2025, Vol. 17 Issue 11, p542. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726651
DOI:10.3390/toxins17110542